CYBN logo

Cybin (CYBN)

Profile

Full Name

Cybin Inc.

Ticker Symbol

CYBN

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

September 13, 2019

Indexes

Not included

Website

http://www.cybin.com

Employees

50

Key Details

Price

$7.35(-1.34%)

Market cap

$154.54M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$7.04(+5.78% YoY)

PE ratio

-

Next earnings date

Jun 26, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.35
CYBN price is $7.35

30-Day Relative Volume

1.66
CYBN 30-day relative volume is 1.66

Price Performance

Price Most recent change

-1.34%
CYBN price was down -1.34% on Apr 17, 2025

Price YTD change

-16.67%
CYBN price is down -16.67% since January 1st

Price 1-year change

-48.42%
CYBN price is down -48.42% year-on-year

Price 3-year change

-75.97%
CYBN price is down -75.97% over the past 3 years

Price Range

Price All-time high

$120.84
CYBN price is currently -93.92% below its historical high of $120.84

Price 3-year low

$0.21
CYBN price is currently +3400.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$154.54M
CYBN market capitalization is $154.54 million

Market cap 3-year change

+15.87%
CYBN market capitalization is up +15.87% over the past 3 years

Market cap All-time high

$1.65B
CYBN market capitalization is currently -90.66% below its historical high of $1.65 billion

Market cap sector rank

53.74%
CYBN market capitalization is higher than 53.74% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+5.12%
CYBN shares outstanding is up +5.12% year-on-year

Shares Outstanding 3-Year Change

+382.23%
CYBN shares outstanding is up +382.23% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.95
CYBN beta is 0.95

200-day SMA

$9.37
CYBN price is currently -21.59% below its 200-day simple moving average

50-day SMA

$7.59
CYBN price is currently -3.15% below its 50-day simple moving average

RSI

55.28
CYBN 14-day relative strength index is 55.28

Volume

1.66
CYBN 30-day relative volume is 1.66

ATR

$0.66
CYBN average true range is $0.66

10-day Historical Volatility

139.32%
CYBN 10-day historical volatility is 139.32%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CYBN annual revenue value is unknown

Revenue Analysts estimate

-
CYBN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CYBN annual revenue 1-year change is unknown

Revenue Sector rank

-
CYBN annual revenue is unknown

EPS

EPS

-$7.04
CYBN annual earnings per share is -$7.04

EPS Analysts estimate

-$3.85
CYBN annual earnings per share is currently +82.89% higher than the consensus analysts' forecast

EPS 1-year change

+5.78%
CYBN annual earnings per share is up +5.78% year-on-year

EPS Sector rank

14.75%
CYBN annual earnings per share is higher than 14.75% of companies in Healthcare sector

Profit

Gross profit

-
CYBN annual gross profit value is unknown

Gross margin

-
CYBN annual gross profit margin value is unknown

Operating profit

-$58.43M
CYBN annual operating income is -$58.43 million

Operating margin

-
CYBN annual operating profit margin value is unknown

Net income

-$57.87M
CYBN annual net profit is -$57.87 million

Net margin

-
CYBN annual net profit margin value is unknown

Expenses

Total expenses

$58.43M
CYBN annual total expenses is $58.43 million

Operating expenses

$58.43M
CYBN annual total operating expenses is $58.43 million

Cost of goods sold

-
CYBN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$33.78M
CYBN annual SGA is $33.78 million

Depreciation and amortization

$314.30K
CYBN annual depreciation & amortization is $314.30 thousand

Interest expense

-
CYBN annual interest expense value is unknown

Income tax

-
CYBN annual income tax value is unknown

EBIT & EBITDA

EBIT

-$58.43M
CYBN annual earnings before interest & taxes is -$58.43 million

EBITDA

-$58.12M
CYBN annual EBITDA is -$58.12 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$223.52M
CYBN annual total assets is $223.52 million

Non current assets

$61.79M
CYBN annual long term assets is $61.79 million

Current assets

$161.73M
CYBN annual total current assets is $161.73 million

Cash and cash equivalents

$154.67M
CYBN annual cash & cash equivalents is $154.67 million

Accounts receivable

$3.31M
CYBN annual accounts receivable is $3.31 million

Inventory

-
CYBN annual inventory value is unknown

Liabilities

Total liabilities

$7.47M
CYBN annual total liabilities is $7.47 million

Long term liabilities

$0.00
CYBN annual total long term liabilities is $0.00

Current liabilities

$7.47M
CYBN annual total current liabilities is $7.47 million

Accounts payable

$7.26M
CYBN annual accounts payable is $7.26 million

Debt

Total debt

$0.00
CYBN annual total debt is $0.00

Total debt 1-year change

0%
CYBN {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
CYBN annual long term debt value is unknown

Short term debt

-
CYBN annual short term debt value is unknown

Equity & Capital

Shareholders equity

$216.05M
CYBN annual stockholders equity is $216.05 million

Book value

$216.05M
CYBN annual book value is $216.05 million

Retained earnings

-$167.43M
CYBN annual retained earnings is -$167.43 million

Working capital

$154.26M
CYBN annual working capital is $154.26 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$51.07M
CYBN annual cash flow from operations is -$51.07 million

Cash from operations 1-year change

-42.36%
CYBN annual cash flow from operations is down -42.36% year-on-year

Cash from investing

$5.13M
CYBN annual cash flow from investing activities is $5.13 million

Cash from investing 1-year change

+304.98%
CYBN annual cash flow from investing activities is up +304.98% year-on-year

Cash from financing

$188.64M
CYBN annual cash flow from financing activities is $188.64 million

Cash from financing 1-year change

+1738.64%
CYBN annual cash flow from financing activities is up +1738.64% year-on-year

CAPEX

CAPEX

-
CYBN annual capital expenditures value is unknown

CAPEX 1-year change

-
CYBN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$51.60M
CYBN annual free cash flow is -$51.60 million

Free cash flow 1-year change

-34.45%
CYBN annual free cash flow is down -34.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CYBN annual gross profit margin value is unknown

Operating margin

-
CYBN annual operating profit margin value is unknown

Net margin

-
CYBN annual net profit margin value is unknown

ROA & ROE

ROA

-25.89%
CYBN annual return on assets is -25.89%

ROE

-26.79%
CYBN annual return on equity is -26.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CYBN price to earnings ratio value is unknown

PE ratio Sector rank

-
CYBN price to earnings ratio is unknown

PB Ratio

PB ratio

0.92
CYBN price to book ratio is 0.92

PB ratio Sector rank

42.29%
CYBN price to book ratio is higher than 42.29% of companies in Healthcare sector

PS Ratio

PS ratio

-
CYBN price to sales ratio value is unknown

PS ratio Sector rank

-
CYBN price to sales ratio is unknown

Enterprise value

Enterprise value

$59.58M
CYBN enterprise value is $59.58 million

Enterprise value Sector rank

43.55%
CYBN enterprise value is higher than 43.55% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.61
CYBN EV/EBITDA is -0.61

EV/EBITDA Sector rank

49.35%
CYBN EV/EBITDA is higher than 49.35% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

21.65
CYBN annual current ratio is 21.65

Quick ratio

-
CYBN annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CYBN annual debt to equity ratio is 0.00

Interest coverage ratio

-
CYBN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CYBN piotroski f-score value is unknown

Altman Z-Score

-
CYBN altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 13, 25 Guggenheim
Buy
Feb 13, 25 HC Wainwright & Co.
Buy
Feb 12, 25 Canaccord Genuity
Buy
Jan 27, 25 HC Wainwright & Co.
Buy
Nov 19, 24 HC Wainwright & Co.
Buy
Nov 19, 24 Canaccord Genuity
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Canaccord Genuity
Buy
Sep 23, 24 Canaccord Genuity
Buy
Aug 23, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

BWAY logo
BrainsWay (BWAY)
NBTX logo
Nanobiotix SA (NBTX)
OPRX logo
OptimizeRx (OPRX)
Actuate Therapeutics (ACTU)
ARAY logo
Accuray Incorporated (ARAY)
JYNT logo
Joint (JYNT)
Aardvark Therapeutics (AARD)
DMAC logo
DiaMedica Therapeutics (DMAC)
MYO logo
Myomo (MYO)
  • What is the ticker symbol for Cybin?
  • Does Cybin pay dividends?
  • What sector is Cybin in?
  • What industry is Cybin in?
  • What country is Cybin based in?
  • When did Cybin go public?
  • Is Cybin in the S&P 500?
  • Is Cybin in the NASDAQ 100?
  • Is Cybin in the Dow Jones?
  • When was Cybin's last earnings report?
  • When does Cybin report earnings?

What is the ticker symbol for Cybin?

The ticker symbol for Cybin is NYSE American:CYBN

Does Cybin pay dividends?

No, Cybin does not pay dividends

What sector is Cybin in?

Cybin is in the Healthcare sector

What industry is Cybin in?

Cybin is in the Biotechnology industry

What country is Cybin based in?

Cybin is headquartered in Canada

When did Cybin go public?

Cybin's initial public offering (IPO) was on September 13, 2019

Is Cybin in the S&P 500?

No, Cybin is not included in the S&P 500 index

Is Cybin in the NASDAQ 100?

No, Cybin is not included in the NASDAQ 100 index

Is Cybin in the Dow Jones?

No, Cybin is not included in the Dow Jones index

When was Cybin's last earnings report?

Cybin's most recent earnings report was on Feb 10, 2025

When does Cybin report earnings?

The next expected earnings date for Cybin is Jun 26, 2025
On this page